Bottom line
QEFA vs FSKLX: the short answer
QEFA (State Street(R) SPDR(R) MSCI EAFE StrategicFactors(SM) ETF) and FSKLX (Fidelity SAI International Low Volatility Index Fund) are quite different portfolios: only about 33% of their top holdings (by weight) are shared.
But QEFA is far broader, holding 647 positions to 132 for FSKLX, so beyond the top names it adds exposure FSKLX doesn't have.
FSKLX is cheaper at 0.16% vs 0.3% — a difference of $14 a year per $10,000 invested.
Over five years, QEFA returned +8.4% a year vs +1.5% for FSKLX.
Updated Nov 19, 2026
QEFA vs FSKLX side by side
| QEFA | FSKLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | SPDR (State Street) | Fidelity |
| Category | International Stock | International Stock |
| Expense ratio | 0.3% | 0.16% |
| Annual cost per $10k | $30 | $16 |
| 10-yr cost on $10k (prospectus) | $381 | $205 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +28.7% | +1.2% |
| 5-yr return (annualized) | +8.4% | +1.5% |
| 10-yr return (annualized) | +8.1% | +3.5% |
| Best quarter | +15.7% | +11.1% |
| Worst quarter | −19.6% | −17.3% |
| Net assets (fund) | $1.0B | $7.9B |
| Number of holdings | 647 | 132 |
| Portfolio turnover | 16% | 23% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | QEFA | FSKLX | Difference |
|---|---|---|---|
| 2024 | +2.7% | +1.2% | +1.5% |
| 2023 | +17.3% | +13.8% | +3.4% |
| 2022 | −14.0% | −13.5% | −0.5% |
| 2021 | +12.4% | +9.9% | +2.5% |
| 2020 | +6.9% | −1.6% | +8.5% |
| 2019 | +21.9% | +16.1% | +5.8% |
| 2018 | −10.2% | −4.9% | −5.4% |
| 2017 | +23.9% | +21.4% | +2.5% |
| 2016 | +0.3% | +2.4% | −2.1% |
Source: Fund prospectus bar charts
Holdings overlap
9 of QEFA's top 25 holdings also appear in FSKLX's top 25.
| Holding | QEFA | FSKLX |
|---|---|---|
| Novartis AG | 2.12% | 1.99% |
| AstraZeneca PLC | 1.86% | 1.73% |
| Roche Holding AG | 1.85% | 1.84% |
| Unilever PLC | 1.15% | 1.68% |
| Shell PLC | 1.08% | 1.95% |
| Zurich Insurance Group AG | 1.05% | 1.97% |
| Gsk Plc | 0.89% | 1.78% |
| British American Tobacco PLC | 0.82% | 1.37% |
| Air Liquide SA | 0.78% | 1.87% |
Source: SEC Form N-PORT
QEFA top 10
- ASML Holding NV — 2.52%
- State Street Global Advisors — 2.49%
- Novartis AG — 2.12%
- AstraZeneca PLC — 1.86%
- Roche Holding AG — 1.85%
- Nestle SA — 1.70%
- Unilever PLC — 1.15%
- Shell PLC — 1.08%
- Zurich Insurance Group AG — 1.05%
- Allianz SE — 1.05%
FSKLX top 10
- Oversea-chinese Bkg Corp Ltd — 2.08%
- Tokio Marine Holdings Inc — 2.02%
- Kyocera Corp — 2.01%
- Novartis Ag — 1.99%
- Zurich Insurance Group Ag — 1.97%
- Shell Plc — 1.95%
- Air Liquide Sa — 1.87%
- Roche Holding Ag — 1.84%
- Gsk Plc — 1.78%
- Astrazeneca Plc — 1.73%
FAQ
What is the difference between QEFA and FSKLX?
Which is cheaper, QEFA or FSKLX?
Should I own both QEFA and FSKLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.